These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10355910)

  • 1. Does perinatal phenobarbital exposure affect developmental outcome at age 2?
    Thorp JA; O'Connor M; Jones AM; Hoffman EL; Belden B
    Am J Perinatol; 1999; 16(2):51-60. PubMed ID: 10355910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation.
    Thorp JA; Ferrette-Smith D; Gaston LA; Johnson J; Yeast JD; Meyer B
    Obstet Gynecol; 1995 Jul; 86(1):1-8. PubMed ID: 7784000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial.
    Thorp JA; Parriott J; Ferrette-Smith D; Meyer BA; Cohen GR; Johnson J
    Obstet Gynecol; 1994 Jan; 83(1):70-6. PubMed ID: 8272312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal phenobarbital therapy and neonatal outcome. II: Neurodevelopmental outcome at 36 months.
    Shankaran S; Woldt E; Nelson J; Bedard M; Delaney-Black V
    Pediatrics; 1996 May; 97(5):649-52. PubMed ID: 8628601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure.
    Shankaran S; Papile LA; Wright LL; Ehrenkranz RA; Mele L; Lemons JA; Korones SB; Stevenson DK; Donovan EF; Stoll BJ; Fanaroff AA; Oh W; Verter J
    Am J Obstet Gynecol; 2002 Jul; 187(1):171-7. PubMed ID: 12114906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of phenobarbital usage for prevention of intraventricular hemorrhage in premature infants: factors related to variation in outcome.
    Tholl DA; Miller TQ; Henderson WG; Myers TF
    Clin Trials Metaanal; 1994 Oct; 29(2-3):177-90. PubMed ID: 10150225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of motor delays in young children with fetal alcohol syndrome to those with prenatal alcohol exposure and with no prenatal alcohol exposure.
    Kalberg WO; Provost B; Tollison SJ; Tabachnick BG; Robinson LK; Eugene Hoyme H; Trujillo PM; Buckley D; Aragon AS; May PA
    Alcohol Clin Exp Res; 2006 Dec; 30(12):2037-45. PubMed ID: 17117969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of prenatal phenobarbital in the prevention of subependymal/intraventricular hemorrhage in premature infants.
    Arroyo-Cabrales LM; Garza-Morales S; Hernández-Peláez G
    Arch Med Res; 1998; 29(3):247-51. PubMed ID: 9775459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial.
    Schulte J; Osborne J; Benson JW; Cooke R; Drayton M; Murphy J; Rennie J; Speidel B
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F31-5. PubMed ID: 15613570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phenobarbital and multiple-dose corticosteroids on developmental outcome at age 7 years.
    Thorp JA; O'Connor M; Belden B; Etzenhouser J; Hoffman EL; Jones PG
    Obstet Gynecol; 2003 Feb; 101(2):363-73. PubMed ID: 12576262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial.
    Dunstan JA; Simmer K; Dixon G; Prescott SL
    Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F45-50. PubMed ID: 17185423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental outcome of drug-exposed children through 30 months: a comparison of Bayley and Bayley-II.
    Schuler ME; Nair P; Harrington D
    Psychol Assess; 2003 Sep; 15(3):435-8. PubMed ID: 14593844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero exposure to phenobarbital and intelligence deficits in adult men.
    Reinisch JM; Sanders SA; Mortensen EL; Rubin DB
    JAMA; 1995 Nov; 274(19):1518-25. PubMed ID: 7474220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
    van Wassenaer AG; Westera J; Houtzager BA; Kok JH
    Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
    Brown MS; Eichorst D; Lala-Black B; Gonzalez R
    Pediatrics; 2009 Oct; 124(4):e681-7. PubMed ID: 19786428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants.
    Polam S; Koons A; Anwar M; Shen-Schwarz S; Hegyi T
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1032-5. PubMed ID: 16275792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does exposure to magnesium sulfate in utero decrease the risk of necrotizing enterocolitis in premature infants?
    Ghidini A; Espada RA; Spong CY
    Acta Obstet Gynecol Scand; 2001 Feb; 80(2):126-9. PubMed ID: 11167206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.